Chris Boshoff will become Pfizer's chief scientific officer and R&D president on January 1, replacing Mikael Dolsten. Roger ...
Pfizer Inc. named oncology research head Chris Boshoff as the drug company’s chief scientific officer while it works to fend ...
Pfizer has promoted its oncology chief to lead all of its research and development operations, in a move that will be closely watched by the activist investor piling pressure on the struggling ...
Leerink notes Pfizer (PFE) announced that Chris Boshoff will become the new Chief Scientific Officer, succeeding Mikael Dolsten. The firm views ...